OÜ Jaan Vogelberg MED DOC is a OÜ based in Raadi alev, registry code 10736653, status: active. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q3 2026 was €0 with employees.
Turnover
0 €
↓ 100.0%vs Q2 2026
State taxes
—
Labour taxes
—
Employees
—
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry Scientific research and development · EMTAK 72
Revenue · 202527 138 €
above 80% of companies
industry median 0 € · companies in the industry: 1 073
Net profit margin · 20253.6 %
above 39% of companies
industry median 13.5 % · companies in the industry: 597
Taxes and turnover
Q4 2023 – Q3 2026
Turnover, € Q3 2026: 0 € · −100.0% vs Q2 2026 · industry median 14 442 € · above 2% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Labour taxes per employee, € Q2 2026: 0 € · industry median 1 893 € · above 2% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
EmployeesQ2 2026: 1 · +0.0% vs Q1 2026State taxes, € Q2 2026: 178 € · +78.0% vs Q1 2026
Figures by quarter
Quarter
Turnover, €
State taxes, €
Labour taxes, €
Employees
Q3 2026
—
—
—
—
Q2 2026
45
178
—
1
Q1 2026
44
100
—
1
Q4 2025
—
217
—
1
Q3 2025
—
—
—
1
Q2 2025
9 046
2 211
1 738
1
Q1 2025
25 372
1 360
715
1
Q4 2024
23 082
610
619
1
Q3 2024
10 022
1 087
1 103
1
Q2 2024
31 402
1 262
1 101
1
Q1 2024
27 392
1 413
663
1
Q4 2023
22 881
—
—
—
Q3 2023
3 090
442
—
—
Q2 2023
1 750
350
—
—
Q1 2023
2 750
435
—
—
Q4 2022
3 236
50
—
—
Q3 2022
5 852
99
99
—
Q2 2022
11 381
116
116
—
Q1 2022
17 091
317
231
—
Financials by year
2016 – 2025
Revenue, € 2025: 27 138 € · −70.3% vs 2024 · industry median 0 € · above 80% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit, € 2025: 978 € · −98.1% vs 2024 · industry median 0 € · above 64% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit margin, % 2025: 3.6 % · −53.3 pp vs the year before · industry median 13.5 % · above 39% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Assets, € thousand 2025: 302 714 € · −2.5% vs 2024Equity, € thousand 2025: 285 366 € · +0.3% vs 2024Employees2025: 0 · −100.0% vs 2024 · industry median 1 · above 2% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Financials by year
Year
Revenue, €
Net profit, €
Labour costs, €
Assets, €
Equity, €
Employees
2025
27 138
978
3 431
302 714
285 366
0
2024
91 474
52 008
10 895
310 519
284 389
1
2023
37 425
26 667
333
268 157
232 381
0
2022
33 408
11 882
1 530
233 153
205 714
0
2021
54 738
26 129
1 995
217 266
193 832
1
2020
75 461
38 613
1 442
202 157
167 703
1
2019
87 521
52 229
2 461
166 160
129 090
1
2018
—
—
—
—
—
1
2017
—
—
—
—
—
1
2016
—
—
—
—
—
1
2015
—
—
—
—
—
1
2014
—
—
—
—
—
1
2013
—
—
—
—
—
1
2012
—
—
—
—
—
1
2011
—
—
—
—
—
1
2010
—
—
—
—
—
1
2009
—
—
—
—
—
1
2008
—
—
—
—
—
1
2007
—
—
—
—
—
1
2006
—
—
—
—
—
1
2005
—
—
—
—
—
1
2004
—
—
—
—
—
1
2003
—
—
—
—
—
1
2002
—
—
—
—
—
1
2001
—
—
—
—
—
1
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
